v3.26.1
Note 2 - IPO and Restructuring (Details Textual)
 9 Months Ended
Mar. 10, 2025
USD ($)
Mar. 07, 2025
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2024
shares
Proceeds from Issuance of Common Stock | $     $ 5,030,000 $ 0  
Common Stock, Shares Authorized (in shares)   50,000,000 50,000,000   200,000
Preferred Stock, Shares Authorized (in shares)   25,000,000      
Master Exchange Agreement [Member]          
Restructuring, Common Stock Shares Outstanding, Percentage   0.96      
Debt Conversion, Original Debt, Amount | $   $ 1,006,377      
Master Exchange Agreement [Member] | Conversion of Total Stones Class B and C Preferred Interests Into Common Stock [Member]          
Conversion of Stock, Shares Issued (in shares)   3,782,641      
Class A Common Interests, Warrants [Member] | TotalStone [Member]          
Class of Warrant or Right, Cancelled During Period (in shares)   1,125      
BP Peptides, LLC [Member] | Master Exchange Agreement [Member]          
Restructuring, Related Party Ownership, Percentage Pre-restructuring   0.773      
Restructuring, Related Party Ownership, Percentage Post-restructuring   0.03      
BPA XIV, LLC [Member] | Master Exchange Agreement [Member]          
Restructuring, Related Party Ownership, Percentage Post-restructuring   0.64      
Financial Advisory and Related Services [Member] | TotalStone [Member]          
Related Party Transaction, Amounts of Transaction | $ $ 200,000        
IPO [Member]          
Stock Issued During Period, Shares, New Issues (in shares)   1,250,000      
Shares Issued, Price Per Share (in dollars per share) | $ / shares   $ 4      
Proceeds from Issuance of Common Stock | $   $ 3,252,000